The Weiner Laboratory at Wistar is dedicated to accelerating DNA -
based vaccine technology.
Not exact matches
Today, Cuba has a hardy biotechnology industry that exports a number of important
vaccines, antibody -
based drugs and other biomedical
technologies.
Cuba exports various
vaccines, antibody -
based drugs and other biomedical
technologies.
It's also a stark contrast to today's egg -
based technology, which takes about six months to produce a mere 100 million doses, according to Alan Shaw, CEO of VaxInnate, a company at the forefront of bacteria -
based vaccine production.
It exports a number of
vaccines, antibody -
based drugs and other biomedical
technologies.
BRUSSELS — CureVac, a company
based in Tübingen, Germany, that develops RNA -
based vaccines and therapies, has won a $ 2 million prize awarded by the European Commission to stimulate new
vaccine technologies that might help the developing world.
There are ongoing studies which focus on the discovery of molecular biomarkers of the VSV - ZEBOV
vaccine in healthy individuals using omics -
based technologies in combination with a systems biology approach,» says Ali Harandi.
IDMIT will contribute 1) To the development and validation of assays
based on flow cytometry and mass cytometry for the evaluation of immune responses in humans and animal models; these tools will be particularly relevant for the identification of signatures of
vaccine efficacy; 2) To the animal model platform, in particularly by providing access to NHP models and to new
technologies for in vivo imaging infections and host responses; 3) To networking activities, in particular by organising a workshop on in vivo imaging.
Synthetic Genomics (SGI) and the J. Craig Venter Institute (JCVI) have formed a new company, Synthetic Genomics
Vaccines (SGVI), to develop next - generation vaccines based on synthetic genome tec
Vaccines (SGVI), to develop next - generation
vaccines based on synthetic genome tec
vaccines based on synthetic genome
technology.
Although some of the most successful
vaccines have been live attenuated forms (e.g. measles
vaccine, oral polio
vaccine), most modern
vaccines are
based on recombinant DNA
technologies in some shape or form.
There her research focused on inventing molecular, bead and array -
based approaches to enable novel
vaccine discovery against infectious and chronic diseases At the University of Texas Southwestern Medical she pursued
technologies that became the
basis of a Texas biotechnology company that was ultimately acquired by MacroGenics, Inc..
Research & Development IAVI worked with the Japanese biotech company DNAVEC,
based in Tsukuba City, to jointly develop an AIDS
vaccine candidate
based on its novel Sendai vector
technology.
On the
basis of
technology, the market is classified into live attenuated
vaccines, inactivated
vaccines, toxoid
vaccines, recombinant
vaccines, and other
vaccines.
Development of a
technology -
based behavioral
vaccine to prevent adolescent depression: A health system integration model (2015)